3d-printing-2019-keynote

3 / 3

August 05-06, 2019 | Paris, France
Euroscicon Conference on 3D Printing
Page 22 American Journal of Computer Science and Information Technology
ISSN: 2349-3917 3D Printing 2019
The 3D printing (3DP) process was patented in 1986; however, only in the last
decade has it been used for medical applications, as well as being utilized
in the fields of prosthetics, bio- fabrication, and pharmaceutical printing. 3DP or
Additive Manufacturing (AM) is a family of technologies that implement layer-
by-layer processes to fabricate physical prototypes, based on a Computer Aided
Design (CAD) model of the design. 3D printing permits the fabrication of high
degrees of complexity with great reproducibility, in a fast and cost-effective
fashion. 3DP technology offers a new paradigm for the direct manufacture of
individual dosage forms, and has the potential to allow variations in their size
and geometry varied to control dose and release behaviour. 3DP thus offers
the perfect innovative manufacturing route to address critical capability gaps
hindering the widespread exploitation of personalised drug delivery systems and
medical devices. Ideally, the design and fabrication of such systems should be
customised to each individual patient.This talk will focus in themanufacturing of
drug delivery systems & medical devices (e.g. catheters, meshes, microneedles,
tablets) using innovative 3D printing technologies. Including in-house prepared
filaments by hot-melt extrusion (HME) and granules/pellets by Twin Screw
Granulation (TSG).
3D Printing in Pharmaceutical and
Medical Device Manufacturing
Dimitrios A. Lamprou
Queen’s University Belfast, UK
Biography
Dimitrios Lamprou (Ph.D., MBA) is Reader in Phar-
maceutical Engineering and MSc Programme Direc-
tor at the School of Pharmacy in Queen's University
Belfast (UK) and Visiting Researcher at University of
Strathclyde (Glasgow, UK). Dimitrios has experience
ofteaching inHigherEducation,conductingresearch
(70+ publications, 200+ conference abstracts, 80+
Oral/Invited Presentations) and securing national
and international funding (£2M+). He is Secretary
at the United Kingdom and Ireland Controlled Re-
lease Society (UKICRS), Ph.D. examiner for UK and
International Institutions, and referees for journals,
publishers and research funding bodies. His group
is applying Nano and Microfabrication Techniques
in Pharmaceutical and Medical Device Manufactur-
ing. More specifically, his areas of interest includes:
Additive Manufacturing (3D Printing & Bioprinting),
Electrospinning (Melt & Solution), and Microfluidics
(Particle Formulations & Chip Manufacturing).
Dimitrios A. Lamprou, Am J Compt Sci Inform Technol 2019, Volume 07